Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer

The aim of this dose escalation study was to determine the maximum-tolerated dose (MTD), dose-limiting toxicities (DLTs) and preliminary efficacy of docetaxel, S-1 and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer. Seventeen patients received oral S-1 (40...

Descripción completa

Detalles Bibliográficos
Autores principales: Takayama, T, Sato, Y, Sagawa, T, Okamoto, T, Nagashima, H, Takahashi, Y, Ohnuma, H, Kuroiwa, G, Miyanishi, K, Takimoto, R, Matsunaga, T, Kato, J, Yamaguchi, K, Hirata, K, Niitsu, Y
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360407/
https://www.ncbi.nlm.nih.gov/pubmed/17848958
http://dx.doi.org/10.1038/sj.bjc.6603957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360407/
https://www.ncbi.nlm.nih.gov/pubmed/17848958
http://dx.doi.org/10.1038/sj.bjc.6603957

Ejemplares similares